A structural keystone for drug design
3D-structures of proteins and potential ligands are the cornerstones of rational drug design. The first brick to build upon is selecting a protein target and finding out whether biologically active compounds are known. Both tasks require more information than the structures themselves provide. For t...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2006-06-01
|
Series: | Journal of Integrative Bioinformatics |
Online Access: | http://www.degruyter.com/view/j/jib.2006.3.issue-1/biecoll-jib-2006-19/biecoll-jib-2006-19.xml?format=INT |
id |
doaj-2a44beb70a98440892c966597fdfdd3a |
---|---|
record_format |
Article |
spelling |
doaj-2a44beb70a98440892c966597fdfdd3a2020-11-25T00:27:50ZengDe GruyterJournal of Integrative Bioinformatics1613-45162006-06-0131213110.1515/jib-2006-19biecoll-jib-2006-19A structural keystone for drug designRother Kristian0Dunkel Mathias1Michalsky Elke2Trissl Silke3Goede Andrean4Leser Ulf5Preissner Robert6Institute of Biochemistry, Charité Universitätsmedizin Berlin, Monbijoustraße 2, 10117 Berlin, GermanyInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Monbijoustraße 2, 10117 Berlin, GermanyInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Monbijoustraße 2, 10117 Berlin, GermanyInstitute of Computer Science, Humboldt-Universität zu Berlin, Unter den Linden 6, 10099 Berlin, GermanyInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Monbijoustraße 2, 10117 Berlin, GermanyInstitute of Computer Science, Humboldt-Universität zu Berlin, Unter den Linden 6, 10099 Berlin, GermanyInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Monbijoustraße 2, 10117 Berlin, Germany3D-structures of proteins and potential ligands are the cornerstones of rational drug design. The first brick to build upon is selecting a protein target and finding out whether biologically active compounds are known. Both tasks require more information than the structures themselves provide. For this purpose we have built a web resource bridging protein and ligand databases. It consists of three parts: i) A data warehouse on annotation of protein structures that integrates many well-known databases such as Swiss-Prot, SCOP, ENZYME and others. ii) A conformational library of structures of approved drugs. iii) A conformational library of ligands from the PDB, linking the realms of proteins and small molecules.http://www.degruyter.com/view/j/jib.2006.3.issue-1/biecoll-jib-2006-19/biecoll-jib-2006-19.xml?format=INT |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rother Kristian Dunkel Mathias Michalsky Elke Trissl Silke Goede Andrean Leser Ulf Preissner Robert |
spellingShingle |
Rother Kristian Dunkel Mathias Michalsky Elke Trissl Silke Goede Andrean Leser Ulf Preissner Robert A structural keystone for drug design Journal of Integrative Bioinformatics |
author_facet |
Rother Kristian Dunkel Mathias Michalsky Elke Trissl Silke Goede Andrean Leser Ulf Preissner Robert |
author_sort |
Rother Kristian |
title |
A structural keystone for drug design |
title_short |
A structural keystone for drug design |
title_full |
A structural keystone for drug design |
title_fullStr |
A structural keystone for drug design |
title_full_unstemmed |
A structural keystone for drug design |
title_sort |
structural keystone for drug design |
publisher |
De Gruyter |
series |
Journal of Integrative Bioinformatics |
issn |
1613-4516 |
publishDate |
2006-06-01 |
description |
3D-structures of proteins and potential ligands are the cornerstones of rational drug design. The first brick to build upon is selecting a protein target and finding out whether biologically active compounds are known. Both tasks require more information than the structures themselves provide. For this purpose we have built a web resource bridging protein and ligand databases. It consists of three parts: i) A data warehouse on annotation of protein structures that integrates many well-known databases such as Swiss-Prot, SCOP, ENZYME and others. ii) A conformational library of structures of approved drugs. iii) A conformational library of ligands from the PDB, linking the realms of proteins and small molecules. |
url |
http://www.degruyter.com/view/j/jib.2006.3.issue-1/biecoll-jib-2006-19/biecoll-jib-2006-19.xml?format=INT |
work_keys_str_mv |
AT rotherkristian astructuralkeystonefordrugdesign AT dunkelmathias astructuralkeystonefordrugdesign AT michalskyelke astructuralkeystonefordrugdesign AT trisslsilke astructuralkeystonefordrugdesign AT goedeandrean astructuralkeystonefordrugdesign AT leserulf astructuralkeystonefordrugdesign AT preissnerrobert astructuralkeystonefordrugdesign AT rotherkristian structuralkeystonefordrugdesign AT dunkelmathias structuralkeystonefordrugdesign AT michalskyelke structuralkeystonefordrugdesign AT trisslsilke structuralkeystonefordrugdesign AT goedeandrean structuralkeystonefordrugdesign AT leserulf structuralkeystonefordrugdesign AT preissnerrobert structuralkeystonefordrugdesign |
_version_ |
1725338190350385152 |